These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8303624)
21. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Reiss TF; Hill JB; Harman E; Zhang J; Tanaka WK; Bronsky E; Guerreiro D; Hendeles L Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894 [TBL] [Abstract][Full Text] [Related]
22. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Christie PE; Tagari P; Ford-Hutchinson AW; Charlesson S; Chee P; Arm JP; Lee TH Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1025-9. PubMed ID: 1850964 [TBL] [Abstract][Full Text] [Related]
23. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587 [TBL] [Abstract][Full Text] [Related]
24. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma. Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550 [TBL] [Abstract][Full Text] [Related]
25. A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Cloud ML; Enas GC; Kemp J; Platts-Mills T; Altman LC; Townley R; Tinkelman D; King T; Middleton E; Sheffer AL Am Rev Respir Dis; 1989 Nov; 140(5):1336-9. PubMed ID: 2554766 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005. Dahlén B; Kumlin M; Ihre E; Zetterström O; Dahlén SE Thorax; 1997 Apr; 52(4):342-7. PubMed ID: 9196517 [TBL] [Abstract][Full Text] [Related]
27. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Nasser SM; Bell GS; Foster S; Spruce KE; MacMillan R; Williams AJ; Lee TH; Arm JP Thorax; 1994 Aug; 49(8):749-56. PubMed ID: 8091318 [TBL] [Abstract][Full Text] [Related]
28. Montelukast: a review of its therapeutic potential in persistent asthma. Jarvis B; Markham A Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041 [TBL] [Abstract][Full Text] [Related]
29. Urinary leukotriene E4 in bronchial asthma. Smith CM; Hawksworth RJ; Thien FC; Christie PE; Lee TH Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055 [TBL] [Abstract][Full Text] [Related]
30. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH Am Rev Respir Dis; 1992 Dec; 146(6):1531-4. PubMed ID: 1333741 [TBL] [Abstract][Full Text] [Related]
31. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Hui KP; Barnes NC Lancet; 1991 May; 337(8749):1062-3. PubMed ID: 1673495 [TBL] [Abstract][Full Text] [Related]
32. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma. Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079 [TBL] [Abstract][Full Text] [Related]
33. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571. Rasmussen JB; Margolskee DJ; Eriksson LO; Williams VC; Andersson KE Ann N Y Acad Sci; 1991; 629():436. PubMed ID: 1952571 [No Abstract] [Full Text] [Related]
34. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of fluticasone and montelukast on allergen-induced asthma. Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933 [TBL] [Abstract][Full Text] [Related]
37. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Hui KP; Taylor IK; Taylor GW; Rubin P; Kesterson J; Barnes NC; Barnes PJ Thorax; 1991 Mar; 46(3):184-9. PubMed ID: 1851340 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219. Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260 [TBL] [Abstract][Full Text] [Related]
39. The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. Taniguchi Y; Tamura G; Honma M; Aizawa T; Maruyama N; Shirato K; Takishima T J Allergy Clin Immunol; 1993 Oct; 92(4):507-12. PubMed ID: 8409112 [TBL] [Abstract][Full Text] [Related]
40. Regulation of the production and action of leukotrienes by MK-571 and MK-886. Ford-Hutchinson AW Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]